Companies: 10,795·Total market cap: $144.5T

Cardax, Inc.

Cardax, Inc.

CDXIOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$80

P/E Ratio—

52W High$0.004

52W Low$0.000001

Avg Volume2

Open$0.00

Beta-13.76

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Cardax, Inc.（CDXI）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CDXI · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-10.03Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)500707.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding744,555Shares outstanding history

Next EarningsTBAEarnings history

探索 Cardax, Inc. 数据

分析师预测—

股息不分红

营收$538946-24.19%

盈利EPS $-6.79+19.17%

财务快照

FY 2020Revenue$538946.00▼ 24.19% YoY

201820192020

FY 2020Net Income-$5.1M▲ +0.74% YoY

201820192020

FY 2020EPS$-6.79▲ +19.17% YoY

201820192020

TTM:Revenue: $500707.00Net Income: -$7.7MEPS: $-10.03View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$0.00+0.00%$80 #2

Eloxx Pharmaceuticals, Inc.

$6.20-31.11%$47.0M #3

Cannabiz Mobile, Inc.

$0.00+0.00%$505 #4

MedAvail Holdings, Inc.

$0.00+0.00%$161 #5

Micron Solutions, Inc.

$0.00+0.00%$317 #6

Modern Technology Corp.

$0.00+0.00%$1,102

股票表现

1D+0.00%

1W+0.00%

1M+0.00%

3M+0.00%

YTD+0.00%

1Y+0.00%

5Y-99.99%

关于 Cardax, Inc.

CEODavid G. Watumull

IPO DateMar 6, 2013

Employees10

CountryUS

Websitecardaxpharma.com

Cardax, Inc. is a biopharmaceutical enterprise focused on both creating and marketing nutritional supplements for maintaining inflammatory well-being, as well as developing pharmaceutical treatments f…

Biotechnology HealthcareOTCUS

关于股票概览与关键数据

Cardax, Inc.（CDXI）是 Biotechnology 行业的 Healthcare 类公司，于 Mar 6, 2013 在 OTC 上市。截至最近交易日，CDXI 股价为 $0.00，市值约为 $80。过去12个月累计回报 +0.00%，年初至今回报 +0.00%。

2020 财年 Cardax, Inc. 营收 $538946.00。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Cardax, Inc.（CDXI）股价为 $0.00，在 OTC 上市，52周区间为 $0.00 – $0.00。

CDXI 最新股价CDXI quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议